Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Joseph C. Sardano Sells 36,093 Shares
Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Joseph C. Sardano Sells 36,093 Shares
Sensus Healthcare, Inc. (NASDAQ:SRTS – Get Rating) CEO Joseph C. Sardano sold 36,093 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $13.97, for a total transaction of $504,219.21. Following the completion of the transaction, the chief executive officer now owns 1,294,200 shares in the company, valued at approximately $18,079,974. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
納斯達克首席執行官約瑟夫·C·薩達諾在一筆日期為8月9日星期二的交易中出售了36,093股該公司股票。這些股票以13.97美元的平均價格出售，總成交金額為504,219.21美元。交易完成後，首席執行官現在擁有該公司1,294,200股，價值約18,079,974美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，該文件可在美國證券交易委員會網站上查閲。
Sensus Healthcare Stock Up 0.3 %
人口普查醫療保健類股上漲0.3%
Shares of SRTS traded up $0.04 during trading hours on Thursday, reaching $14.09. 257,488 shares of the company traded hands, compared to its average volume of 295,234. The company's fifty day moving average price is $9.51 and its two-hundred day moving average price is $9.23. The company has a market capitalization of $234.99 million, a price-to-earnings ratio of 9.33 and a beta of 0.78. Sensus Healthcare, Inc. has a 12 month low of $3.21 and a 12 month high of $14.82.
在週四的交易時間裏，SRT的股價上漲了0.04美元，達到14.09美元。該公司有257,488股易手，而其平均成交量為295,234股。該公司的50日移動均線價格為9.51美元，200日移動均線價格為9.23美元。該公司市值為2.3499億美元，市盈率為9.33倍，貝塔係數為0.78。Scount Healthcare，Inc.的12個月低點為3.21美元，12個月高位為14.82美元。
Analyst Ratings Changes
分析師評級發生變化
Separately, Maxim Group restated a "buy" rating and issued a $14.00 price objective on shares of Sensus Healthcare in a research report on Friday, May 6th.
另外，Maxim Group在5月6日星期五的一份研究報告中重申了“買入”評級，併發布了14.00美元的股票目標價。
Institutional Investors Weigh In On Sensus Healthcare
機構投資者參與人口普查醫療
About Sensus Healthcare
關於人口普查醫療保健
(Get Rating)
(獲取評級)
Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Scount Healthcare，Inc.是一家醫療設備公司，向世界各地的醫療保健提供者製造和銷售放射治療設備。該公司在其治療設備組合中使用了表面放射治療(SRT)，這是一種低能X射線技術。它提供SRT-100，這是一種光子X射線低能量表面放射治療系統，為患者提供治療非黑色素瘤皮膚癌，包括基底細胞和鱗狀細胞皮膚癌，以及瘢痕疙瘩等其他皮膚疾病的替代手術；以及SRT-100 Vision，為用户提供SRT量身定製的治療計劃應用程序，其中集成了嵌入式高頻超聲成像模塊、體積腫瘤分析、束流邊緣規劃和劑量學參數。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Sensus Healthcare (SRTS)
- Why Invest in High-Yield Dividend Stocks?
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Find and Profitably Trade Stocks at 52-Week Lows
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- 免費獲取StockNews.com關於人口普查醫療保健(SRTS)的研究報告
- 為什麼要投資高收益股利股票？
- 迪士尼(NYSE：DIS)的股票剛剛給了投資者一個巨大的信號
- 找到並獲利於52周低點的股票交易
- 清潔能源法案通過後，太陽能股大放異彩
- 顛簸時代的3只穩定成長股
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接收人口普查和醫療保健日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對Scount Healthcare及相關公司評級的每日摘要。
譯文內容由第三人軟體翻譯。